Adaptimmune Therapeutics Plc (ADAP)

Trade ADAP now with
9/7/2021 7:14:43 AM Adaptimmune Enters Strategic Collaboration With Genentech To Develop Allogeneic T-cell Therapies
6/1/2020 10:04:26 PM Adaptimmune Prices Public Offering Of 20.50 Mln ADSs At $11.00/ADS
6/1/2020 6:07:41 AM Adaptimmune Therapeutics Intends To Offer And Sell 12.50 Mln ADSs In Public Offering
5/29/2020 8:52:34 AM Adaptimmune: SPEAR T-cells Targeting MAGE-A4 Show New Responses In EGJ, Lung, Head And Neck Cancers
2/18/2020 8:02:06 AM Adaptimmune Names Gavin Wood As CFO
1/14/2020 2:30:03 AM Astellas, Adaptimmune Enter Co-development And Co-commercialization Agreement
1/13/2020 2:33:16 AM Adaptimmune Says SPEAR T-cell Platform Delivers Initial Responses In Four Solid Tumor Indications